- Filed
- Feb 5, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Jan 31, 2025 | 36.9M sh |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $94.95M |
| Long Term Debt | Q1 2025 · Sep 30, 2024 | $123.19M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $25.94M |
| Cash And Equivalents | Q1 2025 · Sep 30, 2024 | $27.51M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $90.34M |
| Current Liabilities | Q1 2025 · Sep 30, 2024 | $89.34M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $205.44M |
| Total Liabilities | Q1 2025 · Sep 30, 2024 | $234.04M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $145.87M |
| Current Assets | Q1 2025 · Sep 30, 2024 | $154.45M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $796.11M |
| Total Assets | Q1 2025 · Sep 30, 2024 | $815.08M |
| Shares Diluted | Q1 2025 · Dec 31, 2023 | 36.13M sh |
| Stock Repurchased | Q1 2025 · Dec 31, 2023 | $2.17M |
| Capex | Q1 2025 · Dec 31, 2023 | $292K |
| Operating Cash Flow | Q1 2025 · Dec 31, 2023 | $18.67M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $542.08M |
| Stockholders Equity | Q1 2025 · Sep 30, 2023 | $540.49M |
| Eps Diluted | Q1 2025 · Dec 31, 2023 | −$0.08 |
| Eps Basic | Q1 2025 · Dec 31, 2023 | −$0.08 |
| Sga Expense | Q1 2025 · Dec 31, 2023 | $14.69M |
| Net Income | Q1 2025 · Dec 31, 2023 | −$3.05M |
| Operating Income | Q1 2025 · Dec 31, 2023 | $12.13M |
| Gross Profit | Q1 2025 · Dec 31, 2023 | $61.1M |
| Cost Of Revenue | Q1 2025 · Dec 31, 2023 | $44.99M |